Telavancin in Hospital-Acquired and Ventilator-Associated Pneumonia (HAP/VAP) Caused by Staphylococcus aureus: Post Hoc Analysis of 2 Randomized, Controlled Trials
Crossref DOI link: https://doi.org/10.1007/s40121-019-0255-0
Published Online: 2019-08-01
Published Print: 2019-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Niederman, Michael S.
Lee, Patrick C.
Barriere, Steven L.
Barnes, Chris N.
Castaneda-Ruiz, Bibiana
Funding for this research was provided by:
Theravance Biopharma R&D, Inc.
Article History
Received: 18 April 2019
First Online: 1 August 2019